339 related articles for article (PubMed ID: 20488789)
1. Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment?
Sayed BA; Christy AL; Walker ME; Brown MA
J Immunol; 2010 Jun; 184(12):6891-900. PubMed ID: 20488789
[TBL] [Abstract][Full Text] [Related]
2. Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE.
Christy AL; Walker ME; Hessner MJ; Brown MA
J Autoimmun; 2013 May; 42():50-61. PubMed ID: 23267561
[TBL] [Abstract][Full Text] [Related]
3. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
4. T-cell trafficking competence is required for CNS invasion.
Lees JR; Archambault AS; Russell JH
J Neuroimmunol; 2006 Aug; 177(1-2):1-10. PubMed ID: 16822552
[TBL] [Abstract][Full Text] [Related]
5. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.
Renno T; Krakowski M; Piccirillo C; Lin JY; Owens T
J Immunol; 1995 Jan; 154(2):944-53. PubMed ID: 7814894
[TBL] [Abstract][Full Text] [Related]
6. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice.
Tran EH; Hoekstra K; van Rooijen N; Dijkstra CD; Owens T
J Immunol; 1998 Oct; 161(7):3767-75. PubMed ID: 9759903
[TBL] [Abstract][Full Text] [Related]
7. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis.
Karpus WJ; Lukacs NW; McRae BL; Strieter RM; Kunkel SL; Miller SD
J Immunol; 1995 Nov; 155(10):5003-10. PubMed ID: 7594507
[TBL] [Abstract][Full Text] [Related]
8. Meningeal mast cell-T cell crosstalk regulates T cell encephalitogenicity.
Russi AE; Walker-Caulfield ME; Guo Y; Lucchinetti CF; Brown MA
J Autoimmun; 2016 Sep; 73():100-10. PubMed ID: 27396526
[TBL] [Abstract][Full Text] [Related]
9. Human mast cells stimulate activated T cells: implications for multiple sclerosis.
Theoharides TC; Kempuraj D; Kourelis T; Manola A
Ann N Y Acad Sci; 2008 Nov; 1144():74-82. PubMed ID: 19076366
[TBL] [Abstract][Full Text] [Related]
10. Is damage in central nervous system due to inflammation?
Chavarria A; Alcocer-Varela J
Autoimmun Rev; 2004 Jun; 3(4):251-60. PubMed ID: 15246020
[TBL] [Abstract][Full Text] [Related]
11. Preferential distribution of V beta 8.2-positive T cells in the central nervous system of rats with myelin basic protein-induced autoimmune encephalomyelitis.
Tsuchida M; Matsumoto Y; Hirahara H; Hanawa H; Tomiyama K; Abo T
Eur J Immunol; 1993 Oct; 23(10):2399-406. PubMed ID: 7691605
[TBL] [Abstract][Full Text] [Related]
12. The meninges: new therapeutic targets for multiple sclerosis.
Russi AE; Brown MA
Transl Res; 2015 Feb; 165(2):255-69. PubMed ID: 25241937
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system.
Körner H; Lemckert FA; Chaudhri G; Etteldorf S; Sedgwick JD
Eur J Immunol; 1997 Aug; 27(8):1973-81. PubMed ID: 9295034
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic and protective functions of TNF in neuroinflammation are defined by its expression in T lymphocytes and myeloid cells.
Kruglov AA; Lampropoulou V; Fillatreau S; Nedospasov SA
J Immunol; 2011 Dec; 187(11):5660-70. PubMed ID: 22058414
[TBL] [Abstract][Full Text] [Related]
15. Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
Wang C; Wang C; Dong H; Wu XM; Wang C; Xia F; Li G; Jia X; He S; Jiang X; Li H; Xu H
Mol Immunol; 2013 Jan; 53(1-2):43-51. PubMed ID: 22796503
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.
Selmaj K; Raine CS; Cross AH
Ann Neurol; 1991 Nov; 30(5):694-700. PubMed ID: 1722388
[TBL] [Abstract][Full Text] [Related]
17. MASTering the immune response: mast cells in autoimmunity.
Gregory GD; Bickford A; Robbie-Ryan M; Tanzola M; Brown MA
Novartis Found Symp; 2005; 271():215-25; discussion 225-31. PubMed ID: 16605138
[TBL] [Abstract][Full Text] [Related]
18. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H
Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118
[TBL] [Abstract][Full Text] [Related]
19. Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma.
Archambault AS; Sim J; Gimenez MA; Russell JH
Eur J Immunol; 2005 Apr; 35(4):1076-85. PubMed ID: 15761850
[TBL] [Abstract][Full Text] [Related]
20. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
